Abstract. A new method of oligo(nuc1eoside phosphorothi0ate)s (OligoS) synthesis, based on the oligonucleotide chain extention via DBU-catalyzed reaction of 5'-OHnucleoside(-tide)with5'-DMT-nucleoside-3'-0-(2-thiono-1.3.2-oxathiaphospholane)~ (2.) is elaborated. The process of oxathiaphospholane ring opening is shown to be chemo-and stereoselective. The use of separated diastereoisomers of 2 allows the synthesis of OligoS with a predetermined sense of chirality at each internucleotide phosphorothioate function.
INTRODUCTION
Advances in synthetic chemistry and molecular genetics in the past several years have led to new approaches towards the development'of new therapeutics (Ref. 1). These new approaches involve blocking genetic messages to turn off the production of disease-causing proteins. The target here is a nucleotide sequence on a single stranded messenger RNA, which encodes for disease-causing proteins, or double stranded DNA from which mRNA is transcribed. Once a target sequence is determined, complementary or antisense DNA sequence that bind via Watson-Crick type hydrogen bonding and deactivate the genetic message can be synthesized. At 16-28 nuclebtides long, an antisense oligonucleotide is expected to be highly selective in its ability to recognize and bind to its target sequences, since a single mismatch in the complementary strand can reduce the affinity for hybridization by several orders of magnitude. Unmodified synthetic oligonucleotides are not expected to function well as potential therapeutics because they are readily degraded by nucleases. Changes in the phosphodiester-sugar backbone, mostly by replacement of non-bridging oxygens at internucleutide phosphates, led to the first-generation compounds such as oligo (nuc1eoside methanephosph0nate) 
